摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Morpholino adenosine | 179072-93-6

中文名称
——
中文别名
——
英文名称
Morpholino adenosine
英文别名
[(2S,6R)-6-(6-aminopurin-9-yl)morpholin-2-yl]methanol
Morpholino adenosine化学式
CAS
179072-93-6
化学式
C10H14N6O2
mdl
——
分子量
250.26
InChiKey
BYMMQFFKVVGQKW-NKWVEPMBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    571.2±60.0 °C(Predicted)
  • 密度:
    1.80±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -1.4
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    111
  • 氢给体数:
    3
  • 氢受体数:
    7

文献信息

  • [EN] OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF<br/>[FR] COMPOSITIONS D'OLIGONUCLÉOTIDES ET PROCÉDÉS ASSOCIÉS
    申请人:WAVE LIFE SCIENCES LTD
    公开号:WO2022099159A1
    公开(公告)日:2022-05-12
    Among other things, the present disclosure provides oligonucleotides and compositions thereof. In some embodiments, provided oligonucleotides and compositions are useful for adenosine modification. In some embodiments, the present disclosure provides methods for treating various conditions, disorders or diseases that can benefit from adenosine modification.
    除其他事项外,本公开提供寡核苷酸及其组合物。在某些实施例中,提供的寡核苷酸及其组合物对腺苷修饰有用。在某些实施例中,本公开提供了治疗各种需要腺苷修饰的疾病、疾病或病症的方法。
  • TAU-TARGETING OLIGONUCLEOTIDE GAPMERS
    申请人:Eisai R&D Management Co., Ltd.
    公开号:US20220195437A1
    公开(公告)日:2022-06-23
    Antisense oligonucleotides are provided. These antisense oligonucleotides are useful in the preparation of gapmers for inhibition of Tau mRNA transcription. Inhibition of Tau mRNA transcription may result in decrease of amounts of Tau protein in a subject, allowing treatment of diseases and disorders related to expression of Tau, including Alzheimer's disease and primary tauopathies.
    提供了反义寡核苷酸。这些反义寡核苷酸在制备gapmers以抑制Tau mRNA转录方面非常有用。抑制Tau mRNA转录可能导致受试者Tau蛋白质量的降低,从而治疗与Tau表达有关的疾病和疾病,包括阿尔茨海默病和原发性Tau病。
  • [EN] POLY-MORPHOLINO OLIGONUCLEOTIDE GAPMERS<br/>[FR] GAPMÈRES DE POLY-MORPHOLINO OLIGONUCLÉOTIDES
    申请人:[en]EISAI R&D MANAGEMENT CO., LTD.
    公开号:WO2022125987A1
    公开(公告)日:2022-06-16
    Gapmers or pharmaceutically acceptable salt of the gapmers and methods of making the gapmers are provided. The gapmers include a gap region that contains deoxyribonucleosides linked to each other by phosphorothioate bonds, a 5' wing region positioned at the 5' end of the gap region that contains morpholino monomers linked to each other by phosphorodiamidate bonds, and a 3' wing region positioned at the 3' end of the gap region that contains morpholino monomers linked to each other by phosphorodiamidate bonds. Antisense oligonucleotides are also provided. These antisense oligonucleotides are useful in the preparation of gapmers for inhibition of Tau mRNA transcription.
  • [EN] TAU-TARGETING OLIGONUCLEOTIDE GAPMERS<br/>[FR] GAPMÈRES OLIGONUCLÉOTIDIQUES CIBLANT TAU
    申请人:[en]EISAI R&D MANAGEMENT CO., LTD.
    公开号:WO2022125984A1
    公开(公告)日:2022-06-16
    Antisense oligonucleotides are provided. These antisense oligonucleotides are useful in the preparation of gapmers for inhibition of Tau mRNA transcription. Inhibition of Tau mRNA transcription may result in decrease of amounts of Tau protein in a subject, allowing treatment of diseases and disorders related to expression of Tau, including Alzheimer's disease and primary tauopathies.
查看更多